Detalhe da pesquisa
1.
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study.
Liver Int
; 44(4): 920-930, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291865
2.
High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Mediators Inflamm
; 2023: 2664370, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37181808
3.
Slit2 signaling contributes to cholestatic fibrosis in mice by activation of hepatic stellate cells.
Exp Cell Res
; 385(1): 111626, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31545977
4.
Co-Delivery of Doxorubicin and Anti-BCL-2 siRNA by pH-Responsive Polymeric Vector to Overcome Drug Resistance in In Vitro and In Vivo HepG2 Hepatoma Model.
Biomacromolecules
; 19(6): 2248-2256, 2018 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29690766
5.
Aortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammation.
Nanomedicine
; 14(7): 2215-2226, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29964220
6.
Amelioration of cirrhotic portal hypertension by targeted cyclooxygenase-1 siRNA delivery to liver sinusoidal endothelium with polyethylenimine grafted hyaluronic acid.
Nanomedicine
; 13(7): 2329-2339, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28712920
7.
Synthesis and characterization of 3-in-1 multifunctional lipiodol-doped Fe3O4@Poly (diallyl isophthalate) microspheres for arterial embolization, chemotherapy, and imaging.
Biomed Mater
; 19(3)2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38387046
8.
Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence.
Adv Healthc Mater
; 13(6): e2303031, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37848188
9.
Mechanisms and therapeutic strategies to combat the recurrence and progression of hepatocellular carcinoma after thermal ablation.
J Interv Med
; 6(4): 160-169, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38312128
10.
Nanodrug removes physical barrier to promote T-cell infiltration for enhanced cancer immunotherapy.
J Control Release
; 356: 360-372, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36871644
11.
Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation.
Bioact Mater
; 21: 57-68, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36017073
12.
Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study.
Cancer Imaging
; 23(1): 91, 2023 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37749616
13.
HBV suppresses macrophage immune responses by impairing the TCA cycle through the induction of CS/PDHC hyperacetylation.
Hepatol Commun
; 7(11)2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37820280
14.
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases.
Cell Death Dis
; 14(1): 25, 2023 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36639658
15.
Regorafenib enhances anti-tumor efficacy of immune checkpoint inhibitor by regulating IFN-γ/NSDHL/SREBP1/TGF-ß1 axis in hepatocellular carcinoma.
Biomed Pharmacother
; 159: 114254, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669362
16.
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
J Immunother Cancer
; 11(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36813307
17.
Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study.
J Hepatocell Carcinoma
; 9: 157-170, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35300208
18.
Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.
Front Immunol
; 13: 848387, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35300325
19.
CAR NK-92 cells targeting DLL3 kill effectively small cell lung cancer cells in vitro and in vivo.
J Leukoc Biol
; 112(4): 901-911, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35088475
20.
Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma.
Front Oncol
; 11: 638428, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34123790